Actividades asistenciales

Integrated Cold Plunge Therapy System with Hydro-Circulation, Ice- Forming Cooling, Multi-Wavelength Light Therapy, Sound Therapy, and Mobility Enhancement

24/09/2026 - An integrated cold plunge therapy system comprising: a hydro-circulation subsystem with single or multiple pump configurations and directional nozzles; an ice-forming cooling mechanism using...

USE OF BETA-CATENIN ANTAGONIST AND MAPK INHIBITOR

01/10/2026 - Provided are methods of administering a peptide antagonist of β-catenin in combination with an inhibitor of the mitogen-activated protein kinase (MAPK) signaling pathway.

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING TUMORS AND PREPARATION METHOD AND APPLICATION THEREOF

24/09/2026 - The invention relates to the field of traditional Chinese medicine, particularly to a traditional Chinese medicine composition for treating tumors and a preparation method and an application...

LIFTING AGENT WITH THERAPEUTICS

08/10/2026 - [0000] In the present disclosure, lifting agents are provided with different therapeutic agents to deliver different therapies. These therapies include chemotherapy, healing promotion,...

INTEGRATED SYSTEM AND METHOD FOR AUTOMATED OXYGEN THERAPY MANAGEMENT WITH REMOTE MONITORING AND CONTROL

10/09/2026 - A universal retrofittable system for automated oxygen therapy management comprises a flow control hardware device connecting as an add-on between existing oxygen sources and patient oxygen lines....

METHODS OF USING A COMBINATION OF ALTERNATING ELECTRIC FIELDS, RADIATION THERAPY, TEMOZOLOMIDE AND CHECKPOINT INHIBITORS

01/10/2026 - [0000] Disclosed are methods of treating a subject having glioblastoma comprising a treatment phase and a maintenance phase, wherein the treatment phase comprises applying an alternating...

METHOD FOR TREATING MELASMA USING LONG-ACTING WHITENING INJECTION COMBINED WITH IPL AND 1064 NM LASER

02/10/2026 - The invention provides a method for treating melasma using a long-acting whitening injection combined with IPL and 1064 nm laser, belonging to the technical field of medical aesthetics. A...

METHODS OF USING A COMBINATION OF ALTERNATING ELECTRIC FIELDS, RADIATION THERAPY, TEMOZOLOMIDE AND CHECKPOINT INHIBITORS

COMBINATION THERAPY COMPRISING A MULTI-SPECIFIC BINDING AGENT TARGETING PD-1/PD-L1 AND VEGF/VEGFR AND A MULTI-SPECIFIC BINDING AGENT TARGETING EPCAM AND 4-1BB FOR CANCER TREATMENT

17/09/2026 - The present disclosure relates to combination therapy using a binding agent that binds to (i) PD-1, PD-L1, or both, and (ii) VEGF, VEGF receptor (VEGFR), or both in combination with a binding...

CRYSTAL FORM OF A PARP1 INHIBITOR SALT AND PREPARATION THEREOF

17/09/2026 - A crystal form (Type A) of the bis-tartrate ((2R,3R)) salt of 7-((4-(2-fluoro-6- (methylcarbamoyl)pyridin-3-yl)piperazin-1-yl)methyl)-3,6-difluoropyrazolo[1,5- a]quinoxalin-4(5H)-one (Formula...

T CELL RECEPTORS (TCRS) TARGETING ACTIN-LIKE PROTEIN 8 (ACTL8) FOR USE IN THERAPY

17/09/2026 - The present invention provides, amongst others, a T cell receptor (TCR) that binds to an epitope of human Actin-like protein 8 (ACTL8), wherein said epitope consists of the amino acid sequence of...

ANTI-KIT ANTIBODY DOSING AND METHODS

03/09/2026 - Provided herein are methods for using antibodies that immunospecifically bind to KIT, a receptor tyrosine kinase, in particular barzolvolimab, to treat, manage or prevent prurigo. Also provided...

Ecological vegetation regreening device suitable for building ridges and retaining water for tailings ponds

07/07/2026 - The invention discloses a bank building and water retention ecological vegetation regreening device suitable for a tailing pond, and belongs to the technical field of tailing pond ecological...

ENDOSCOPE SYSTEM, METHOD FOR OPERATING ENDOSCOPE SYSTEM, AND METHOD FOR CONTROLLING ENDOSCOPE SYSTEM

03/09/2026 - Provided is an endoscope system 1 that appropriately irradiates a target site with light. The endoscope system 1 comprises: an optical probe 30 for guiding light from a therapeutic light source 20...

NANOPARTICLE-DECORATED CELLS AND USE THEREOF

10/09/2026 - Nanoconjugates comprising myeloid-derived suppressor cells conjugated to nanoparticles optionally encapsulating therapeutic agents, nanoparticles comprising poly( lactic-co-glycolic acid),...

CRYSTALLINE FORM OF SUBSTITUTED BENZOIMIDIZOLE COMPOUND

10/09/2026 - The present application relates to solid forms of N-(1-(tert-butyl)-6-cyano-4,7-difluoro- 1H-benzo[d]imidazole-2-yl)-3,3-dimethylbutanamide (I) pharmaceutical compositions and methods of use...

Treatment of Inflammation in the Central Nervous System

10/09/2026 - The present invention pertains to the anti-inflammatory therapeutic effect of xantohumol in spinal cord injury (SCI). The continuous administration of xanthohumol for 1-8 weeks to SCI rats...

PREDICTING A TREATABLE HUNTINGTON'S DISEASE PATIENT/PATIENT POPULATION AND EFFECTS ON DISEASE PROGRESSION FOR THERAPIES TARGETING SOMATIC INSTABILITY

27/08/2026 - Somatic instability (SI) in the mutant HTT allele is a high value therapeutic target for Huntington's Disease (HD). However, rates of SI and the speed of HD progression vary widely with inherited...

Method of Treating Cancer

10/09/2026 - A method to enhance immune checkpoint blockade in breast cancer and other solid tumors and hematologic tumors by administering a PD-1/PD-L1 inhibitor together with branched-chain amino acids...

Anti-human integrin alpha3/Beta1 antibodies and methods of use therefor

10/09/2026 - [0000] Disclosed is a monoclonal antibody, MAb51-31 mAb, and its fragments and derivatives that recognize a conformational epitope of human integrin α3/β1 (ITGα3/β1) complex, which is...

ENGINEERED IGA ANTI-EPITHELIAL CELL ADHESION MOLECULE

10/09/2026 - Provided herein are engineered IgA antibodies that comprises: (a) an EPCAM binding domain and (b) an IgA heavy chain constant region. Also, provided herein are methods of treating cancer in a...